Reproductive Tract Bleeding in Adolescent and Young Adult Females with Inherited Bleeding Disorders: An Underappreciated Problem


      Reproductive tract bleeding is an underappreciated health care problem among adolescent and young adult (AYA) females with inherited bleeding disorders (IBDs) comprising von Willebrand disease, platelet disorders, hemophilia carriership, and rare factor deficiencies. IBDs are prevalent in women of all ages and have been detected in about 50% of women with menorrhagia or heavy menstrual bleeding (HMB) and about 20% of women with postpartum hemorrhage (PPH). The clinical spectrum of gynecologic and obstetric bleeding in AYA with IBDs ranges from HMB, ovulation bleeding, and surgical bleeding to miscarriages and life-threatening PPH. Reproductive tract bleeding adversely affects the quality of life of this patient population, in addition to causing substantial morbidity and mortality. Early diagnosis of IBDs offers the opportunity for timely intervention with hormones, hemostatic agents, and prophylaxis with factor concentrates, thereby improving outcomes. This review summarizes the epidemiology, pathophysiology, clinical manifestations, diagnostic approach, management, and prophylaxis for reproductive tract bleeding in AYA with IBDs. This review provides a multidisciplinary approach to the problem, which is critical to improve the outcomes of this patient population.


      Ang-1 (Angiopoietin-1), APH (Ante-partum hemorrhage), ATHN (American Thrombosis and Hemostasis Network), AYA (Adolescents and young adults), BMI (Body mass index), CDC (Centers for Disease Control), CHC (Combined hormonal contraception), COCs (Combined oral contraceptives), DDAVP (l-desamino-8-D-arginine-vasopressin), DIC (Disseminated intravascular coagulation), DMPA (Depot medroxy-progesterone acetate), FFP (Fresh frozen plasma), FUDC (Female Universal Data Collection), HESC (Human endometrial stromal cells), HMB (Heavy menstrual bleeding), HTC (Hemophilia treatment center), IBDs (Inherited bleeding disorders), IUD (Intrauterine device), ISTH-BAT (International Society of Haemostasis and Thrombosis Bleeding Assessment Tool), MMP (Matrix metalloprotease), PAI-1 (Plasminogen activator inhibitor-1), PAR-2 (Protease activating receptor-2), PBAC (Pictorial bleeding assessment chart), PCC (Prothrombin complex concentrate), PCOS (Polycystic ovarian syndrome), PFA (Platelet function analyzer), PFD (Platelet function defect), PPH (Postpartum hemorrhage), PT (Prothrombin time), PTT (Partial thromboplastin time), RFD (Rare factor deficiencies), TEG (Thrombo-elastography), TF (Tissue factor), TGA (Thrombin generation assay), t-PA (Tissue plasminogen activator), TXA (Tranexamic acid), UDC (Universal Data Collection), VEGF (Vascular endothelial growth factor), VTE (Venous thromboembolism), VWD (Von Willebrand disease), VWF (Von Willebrand factor)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • James AH
        Women and bleeding disorders.
        Haemophilia. 2010; 16: 160-167
        • Hermans C
        • Kulkarni R
        Women with bleeding disorders.
        Haemophilia. 2018; 24: 29-36
        • Venkateswaran L
        • Dietrich JE
        Gynecologic concerns in pubertal females with blood disorders.
        J Pediatr Adolesc Gynecol. 2013; 26: 80-85
        • James AH
        More than menorrhagia: a review of the obstetric and gynaecological manifestations of von Willebrand disease.
        Thromb Res. 2007; 120: S17-S20
        • Powers JM
        • Stanek JR
        • Srivaths L
        • et al.
        Hematologic considerations and management of adolescent girls with heavy menstrual bleeding and anemia in US children's hospitals.
        J Pediatr Adolesc Gynecol. 2018; 31: 446-450
        • Cooke AG
        • McCavit TL
        • Buchanan GR
        • Powers JM
        Iron deficiency anemia in adolescents who present with heavy menstrual bleeding.
        J Pediatr Adolesc Gynecol. 2017; 30: 247-250
        • Collier AY
        • Molina RL
        Maternal mortality in the United States: updates on trends, causes, and solutions.
        Neoreviews. 2019; 20: e561-e574
        • Kadir RA
        • Davies J
        • Winikoff R
        • et al.
        Pregnancy complications and obstetric care in women with inherited bleeding disorders.
        Haemophilia. 2013; 19: 1-10
        • Baker JR
        • Riske B
        • Drake JH
        • et al.
        US hemophilia treatment center population trends 1990-2010: patient diagnoses, demographics, health services utilization.
        Haemophilia. 2013; 19: 21-26
        • Byams VR
        • Kouides PA
        • Kulkarni R
        • et al.
        Surveillance of female patients with inherited bleeding disorders in United States haemophilia treatment centres.
        Haemophilia. 2011; 17: 6-13
        • Philipp CS
        • Faiz A
        • Dowling N
        • et al.
        Age and the prevalence of bleeding disorders in women with menorrhagia.
        Obstet Gynecol. 2005; 105: 61-66
        • Veen CSB
        • van der Reijken IS
        • Jansen AJG
        • et al.
        Severe postpartum haemorrhage as first presenting symptom of an inherited bleeding disorder.
        Haemophilia. 2019; 25: 1051-1058
        • Haley KM
        • Sidonio Jr, RF
        • Abraham S
        • et al.
        A cross-sectional study of women and girls with congenital bleeding disorders: the American Thrombosis and Hemostasis Network Cohort.
        J Womens Health (Larchmt). 2020; 29: 670-676
        • Hoffman M
        A cell-based model of coagulation and the role of factor VIIa.
        Blood Rev. 2003; 17: S1-S5
        • Krikun G
        • Lockwood CJ
        • Paidas MJ
        Tissue factor and the endometrium: from physiology to pathology.
        Thromb Res. 2009; 124: 393-396
        • Lockwood CJ
        Mechanisms of normal and abnormal endometrial bleeding.
        Menopause. 2011; 18: 408-411
        • Lockwood CJ
        • Krikun G
        • Runic R
        • et al.
        Progestin-epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells.
        J Clin Endocrinol Metab. 2000; 85: 297-301
        • Plug I
        • Mauser-Bunschoten EP
        • Bröcker-Vriends AH
        • et al.
        Bleeding in carriers of hemophilia.
        Blood. 2006; 108: 52-56
        • Diaz R
        • Dietrich JE
        • Mahoney Jr, D
        • et al.
        Hemostatic abnormalities in young females with heavy menstrual bleeding.
        J Pediatr Adolesc Gynecol. 2014; 27: 324-329
        • Rugeri L
        • Martinaud C
        • Beurrier P
        • et al.
        Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency.
        Thromb Res. 2020; 191: 22-25
        • Kaplinsky C
        • Kenet G
        • Seligsohn U
        • Rechavi G
        Association between hyperflexibility of the thumb and an unexplained bleeding tendency: is it a rule of thumb?.
        Brit J Haematol. 1998; 101: 260-263
        • Castori M
        • Morlino S
        • Dordoni C
        • et al.
        Gynecologic and obstetric implications of the joint hypermobility syndrome (a.k.a. Ehlers-Danlos syndrome hypermobility type) in 82 Italian patients.
        Am J Med Genet A. 2012; (158a): 2176-2182
        • Smits-Engelsman B
        • Klerks M
        • Kirby A
        Beighton score: a valid measure for generalized hypermobility in children.
        J Pediatr. 2011; 158 (119-123, 123 e1-4)
        • van der Giessen LJ
        • Liekens D
        • Rutgers KJM
        • et al.
        Validation of Beighton score and prevalence of connective tissue signs in 773 Dutch children.
        J Rheumatol. 2001; 28: 2726-2730
        • Rodeghiero F
        • Tosetto A
        • Abshire T
        • et al.
        ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.
        J Thromb Haemost. 2010; 8: 2063-2065
        • Elbatarny M
        • Mollah S
        • Grabell J
        • et al.
        Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project.
        Haemophilia. 2014; 20: 831-835
        • Tosetto A
        • Castaman G
        • Plug I
        • et al.
        Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation.
        J Thromb Haemost. 2011; 9: 1143-1148
        • Philipp CS
        • Faiz A
        • Heit JA
        • et al.
        Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.
        Am J Obstet Gynecol. 2011; 204 (ARTN 209.e1)
        • Zakherah MS
        • Sayed GH
        • El-Nashar SA
        • Shaaban MM
        Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin.
        Gynecol Obstet Investig. 2011; 71: 281-284
        • Janssen CA
        • Scholten PC
        • Heintz AP
        A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.
        Obstet Gynecol. 1995; 85: 977-982
        • O’Brien SH
        Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist.
        Hematol Am Soc Hematol Educ Progr. 2018; 2018: 390-398
        • Higham JM
        • O'Brien PM
        • Shaw RW
        Assessment of menstrual blood loss using a pictorial chart.
        Br J Obstet Gynaecol. 1990; 97: 734-739
        • Moon LM
        • Perez-Milicua G
        • Dietrich JE
        Evaluation and management of heavy menstrual bleeding in adolescents.
        Curr Opin Obstet Gynecol. 2017; 29: 328-336
        • Haamid F
        • Sass AE
        • Dietrich JE
        Heavy menstrual bleeding in adolescents.
        J Pediatr Adolesc Gynecol. 2017; 30: 335-340
        • Davies J
        • Kadir RA
        Heavy menstrual bleeding: an update on management.
        Thromb Res. 2017; 151: S70-S77
        • Zia A
        • Kouides P
        • Khodyakov D
        • et al.
        Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric/neonatal and women's health SSCs.
        J Thromb Haemost. 2020; 18: 2759-2774
        • James AH
        Bleeding disorders in adolescents.
        Obstet Gynecol Clin N Am. 2009; 36: 153-162
        • Fressinaud E
        • Veyradier A
        • Truchaud F
        • et al.
        Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases.
        Blood. 1998; 91: 1325-1331
        • Harrison P
        Platelet function analysis.
        Blood Rev. 2005; 19: 111-123
        • Mokhtar GM
        • Ibrahim WE
        • Kassim NA
        • et al.
        Alterations of platelet functions in children and adolescents with iron-deficiency anemia and response to therapy.
        Platelets. 2015; 26: 448-452
        • Lazanyi M
        • Grover SR
        Reducing unnecessary investigations in adolescent gynaecology: the utility of pelvic ultrasonography for adolescents presenting with heavy menstrual bleeding.
        Aust J Gen Pract. 2020; 49: 70-72
        • Peuranpää P
        • Heliövaara-Peippo S
        • Fraser I
        • et al.
        Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding.
        Acta Obstet Gynecol Scand. 2014; 93: 654-660
        • Stoffel NU
        • Cercamondi CI
        • Brittenham G
        • et al.
        Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials.
        Lancet Haematol. 2017; 4: e524-e533
        • Moretti D
        • Goede JS
        • Zeder C
        • et al.
        Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women.
        Blood. 2015; 126: 1981-1989
        • Stanley J
        • Adeyemi-Fowode O
        Intrauterine Foley balloon catheter to manage acute heavy menstrual bleeding in a perimenarchal 10-year-old girl.
        Obstet Gynecol. 2019; 134: 77-80
      1. Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding: ACOG Committee Opinion Summary, Number 785.
        Obstet Gynecol. 2019; 134: 658-659
        • James AH
        • Kouides PA
        • Abdul-Kadir R
        • et al.
        Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel.
        Eur J Obstet Gynecol Reprod Biol. 2011; 158: 124-134
        • Perlman S
        • Nakajima S
        • Hertweek S
        Clinical Protocols in Pediatric and Adolescent Gynecology.
        Parthenon, Boca Raton2004: 36-39
        • Bryant-Smith AC
        • Lethaby A
        • Farquhar C
        • Hickey M
        Antifibrinolytics for heavy menstrual bleeding.
        Cochrane Database Syst Rev. 2018; 4CD000249
        • Deligeoroglou E
        • Karountzos V
        Abnormal uterine bleeding including coagulopathies and other menstrual disorders.
        Best Pract Res Clin Obstet Gynaecol. 2018; 48: 51-61
        • DeVore GR
        • Owens O
        • Kase N
        Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding–a double-blind randomized control study.
        Obstet Gynecol. 1982; 59: 285-291
        • Munro MG
        • Mainor N
        • Basu R
        • et al.
        Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial.
        Obstet Gynecol. 2006; 108: 924-929
        • Agostino H
        • Di Meglio G
        Low-dose oral contraceptives in adolescents: how low can you go?.
        J Pediatr Adolesc Gynecol. 2010; 23: 195-201
        • Goshtasebi A
        • Subotic Brajic T
        • Scholes D
        • et al.
        Adolescent use of combined hormonal contraception and peak bone mineral density accrual: a meta-analysis of international prospective controlled studies.
        Clin Endocrinol (Oxf). 2019; 90: 517-524
        • Van Vliet HA
        • Grimes DA
        • Lopez LM
        • et al.
        Triphasic versus monophasic oral contraceptives for contraception.
        Cochrane Database Syst Rev. 2011; 2011Cd003553
        • Kingman CE
        • Kadir RA
        • Lee CA
        • Economides DL
        The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.
        Br J Obstet Gynaecol. 2004; 111: 1425-1428
        • Chi C
        • Huq FY
        • Kadir RA
        Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.
        Contraception. 2011; 83: 242-247
        • Huguelet PS
        • Laurin JL
        • Thornhill D
        • Moyer G
        Use of the levonorgestrel intrauterine system to treat heavy menstrual bleeding in adolescents and young adults with inherited bleeding disorders and Ehlers-Danlos syndrome.
        J Pediatr Adolesc Gynecol. 2022; 35: 147-152
        • Diedrich JT
        • Klein DA
        • Peipert JF
        Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
        Am J Obstet Gynecol. 2017; 216 (364.e1-364.e12)
        • Adeyemi-Fowode OA
        • Santos XM
        • Dietrich JE
        • Srivaths L
        Levonorgestrel-releasing intrauterine device use in female adolescents with heavy menstrual bleeding and bleeding disorders: single institution review.
        J Pediatr Adolesc Gynecol. 2017; 30: 479-483
        • Gynecologists ACoOa
        Adolescents and long-acting reversible contraception: implants and intrauterine devices. Committee Opinion No. 735.
        Obstet Gynecol. 2018; 131: e130
        • Keenahan L
        • Bercaw-Pratt JL
        • Adeyemi O
        • et al.
        Rates of intrauterine device expulsion among adolescents and young women.
        J Pediatr Adolesc Gynecol. 2021; 34: 362-365
        • Zigler RE
        • McNicholas C
        Unscheduled vaginal bleeding with progestin-only contraceptive use.
        Am J Obstet Gynecol. 2017; 216: 443-450
        • Kuhnz W
        • Heuner A
        • Humpel M
        • et al.
        In vivo conversion of norethisterone and norethisterone acetate to ethinyl estradiol in postmenopausal women.
        Contraception. 1997; 56: 379-385
        • Chu MC
        • Zhang X
        • Gentzschein E
        • et al.
        Formation of ethinyl estradiol in women during treatment with norethindrone acetate.
        J Clin Endocrinol Metab. 2007; 92: 2205-2207
        • Reed MJ
        • Ross MS
        • Lai LC
        • et al.
        In vivo conversion of norethisterone to ethynyloestradiol in perimenopausal women.
        J Steroid Biochem Mol Biol. 1990; 37: 301-303
        • Bottini E
        • Pareti FI
        • Mari D
        • et al.
        Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports.
        Haematologica. 1991; 76: 431-433
        • Payne JH
        • Maclean RM
        • Hampton KK
        • et al.
        Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.
        Haemophilia. 2007; 13: 93-97
        • Kouides PA
        • Byams VR
        • Philipp CS
        • et al.
        Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
        Br J Haematol. 2009; 145: 212-220
        • O'Brien SH
        • Saini S
        • Ziegler H
        • et al.
        An open-label, single-arm, efficacy study of tranexamic acid in adolescents with heavy menstrual bleeding.
        J Pediatr Adolesc Gynecol. 2019; 32: 305-311
        • Matteson KA
        • Rahn DD
        • Wheeler 2nd, TL
        • et al.
        Nonsurgical management of heavy menstrual bleeding: a systematic review.
        Obstet Gynecol. 2013; 121: 632-643
        • Amesse LS
        • Pfaff-Amesse T
        • Leonardi R
        • et al.
        Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study.
        J Pediatr Hematol Oncol. 2005; 27: 357-363
        • Lethagen S
        • Ragnarson Tennvall G
        Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors.
        Ann Hematol. 1993; 66: 257-260
        • Ragni MV
        • Machin N
        • Malec LM
        • et al.
        Von Willebrand factor for menorrhagia: a survey and literature review.
        Haemophilia. 2016; 22: 397-402
        • Balci YI
        • Karabulut A
        • Kabukcu S
        • et al.
        Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
        Clin Appl Thromb Hemost. 2011; 17: 320-322
        • Ozelo MC
        • Svirin P
        • Larina L
        Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
        Ann Hematol. 2005; 84: 816-822
        • Özdemir Ö
        • Sarı ME
        • Kurt A
        • et al.
        Recurrent massive haemoperitoneum associated with ruptured corpus luteum in women with congenital afibrinogenemia; case report.
        Turk J Obstet Gynecol. 2014; 11: 242-245
        • Rouzi AA
        • Qari MH
        • Ardawi MS
        The use of fresh frozen plasma for reproduction in severe factor V deficiency.
        Clin Exp Obstet Gynecol. 2015; 42: 384-385
        • Huq FY
        • Kulkarni A
        • Agbim EC
        • et al.
        Changes in the levels of factor VIII and von Willebrand factor in the puerperium.
        Haemophilia. 2012; 18: 241-245
        • Lavin M
        • Aguila S
        • Dalton N
        • et al.
        Significant gynecological bleeding in women with low von Willebrand factor levels.
        Blood Adv. 2018; 2: 1784-1791
        • Stirling Y
        • Woolf L
        • North WR
        • et al.
        Haemostasis in normal pregnancy.
        Thromb Haemost. 1984; 52: 176-182
        • Kadir R
        • Chi C
        • Bolton-Maggs P
        Pregnancy and rare bleeding disorders.
        Haemophilia. 2009; 15: 990-1005
        • Chi C
        • Lee CA
        • Shiltagh N
        • et al.
        Pregnancy in carriers of haemophilia.
        Haemophilia. 2008; 14: 56-64
        • Konje JC
        • Murphy P
        • de Chazal R
        • et al.
        Severe factor X deficiency and successful pregnancy.
        Br J Obstet Gynaecol. 1994; 101: 910-911
        • Sharief LT
        • Lawrie AS
        • Mackie I.J
        • et al.
        Changes in factor XIII level during pregnancy.
        Haemophilia. 2014; 20: e144-e148
        • Mumford AD
        • Ackroyd S
        • Alikhan R
        • et al.
        Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology.
        Br J Haematol. 2014; 167: 304-326
        • Novikova N
        • Hofmeyr GJ
        • Cluver C
        Tranexamic acid for preventing postpartum haemorrhage.
        Cochrane Database Syst Rev. 2015; CD007872
        • Castaman G
        • James PD
        Pregnancy and delivery in women with von Willebrand disease.
        Eur J Haematol. 2019; 103: 73-79
      2. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
        Lancet. 2017; 389: 2105-2116
        • Ferrer P
        • Roberts I
        • Sydenham E
        • et al.
        Anti-fibrinolytic agents in post partum haemorrhage: a systematic review.
        BMC Pregnancy Childbirth. 2009; 9: 29
        • Shapiro A
        The use of prophylaxis in the treatment of rare bleeding disorders.
        Thromb Res. 2020; 196: 590-602
        • Morimoto N
        • Tanaka T
        • Taiji H
        • et al.
        Hearing loss in Turner syndrome.
        J Pediatr. 2006; 149: 697-701
        • Chi C
        • Pollard D
        • Tuddenham EG
        • Kadir RA
        Menorrhagia in adolescents with inherited bleeding disorders.
        J Pediatr Adolesc Gynecol. 2010; 23: 215-222
        • Siboni SM
        • Spreafico M
        • Calò L
        • et al.
        Gynaecological and obstetrical problems in women with different bleeding disorders.
        Haemophilia. 2009; 15: 1291-1299
        • Sidonio RF
        • Mili FD
        • Li T
        • et al.
        Females with FVIII and FIX deficiency have reduced joint range of motion.
        Am J Hematol. 2014; 89: 831-836
        • James AH
        Von Willebrand disease.
        Obstet Gynecol Surv. 2006; 61: 136-145
        • Kirtava A
        • Drews C
        • Lally C
        • et al.
        Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study.
        Haemophilia. 2003; 9: 292-297
        • Kouides PA
        • Phatak PD
        • Burkart P
        • et al.
        Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey.
        Haemophilia. 2000; 6: 643-648
        • Mills HL
        • Abdel-Baki MS
        • Teruya J
        • et al.
        Platelet function defects in adolescents with heavy menstrual bleeding.
        Haemophilia. 2014; 20: 249-254
        • Paroskie A
        • Gailani D
        • DeBaun MR
        • Sidonio Jr, RF
        A cross-sectional study of bleeding phenotype in haemophilia A carriers.
        Br J Haematol. 2015; 170: 223-228
        • Spiliopoulos D
        • Kadir RA
        Congenital factor V and VIII deficiency in women: a systematic review of literature and report of two new cases.
        Blood Coagul Fibrinolysis. 2016; 27: 237-241
        • Spiliopoulos D
        • Kadir RA
        Congenital Factor X deficiency in women: a systematic review of the literature.
        Haemophilia. 2019; 25: 195-204
        • Wiewel-Verschueren S
        • Arendz IJ
        • Knol HM
        • Meijer K
        Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.
        Haemophilia. 2016; 22: 188-195
        • Sharief LA
        • Kadir RA
        Congenital factor XIII deficiency in women: a systematic review of literature.
        Haemophilia. 2013; 19: e349-e357
        • Herrmann FH
        • Wulff K
        • Auerswald G
        • et al.
        Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.
        Haemophilia. 2009; 15: 267-280
        • Silwer J
        Von Willebrand's disease in Sweden.
        Acta Paediatr Scand Suppl. 1973; 238: 1-159
        • Greer IA
        • Lowe GD
        • Walker JJ
        • Forbes CD
        Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies.
        Br J Obstet Gynaecol. 1991; 98: 909-918
        • Imperiale L
        • Manganaro L
        • Ticino A
        • et al.
        Endometriosis and Glanzmanns thrombasthenia.
        J Biol Regul Homeost Agents. 2016; 30: 877-882
        • Cetinkaya SE
        • Pabuccu EG
        • Ozmen B
        • Dokmeci F
        Recurrent massive hemoperitoneum due to ovulation as a clinical sign in congenital afibrinogenemia.
        Acta Obstet Gynecol Scand. 2011; 90: 192-194
        • Kim JH
        • Jeong SY
        • Cho DH
        Massive hemoperitoneum due to a ruptured corpus luteum cyst in a patient with congenital hypofibrinogenemia.
        Obstet Gynecol Sci. 2015; 58: 427-430
        • Lak M
        • Peyvandi F
        • Ali Sharifian A
        • et al.
        Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency.
        J Thromb Haemost. 2003; 1: 1852-1853
        • Chakravarty C
        • Sivakumaran S
        • Punk J
        • et al.
        Acute abdomen in a young girl with Factor XIII deficiency perianesthetic issues.
        J Obstet Gynaecol India. 2012; 62: 205-206
        • Salomon O
        • Steinberg DM
        • Seligshon U
        Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy.
        Haemophilia. 2006; 12: 490-493
        • Noris P
        • Schlegel N
        • Klersy C
        • et al.
        Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.
        Haematologica. 2014; 99: 1387-1394
        • Reeves JA
        • Dowlut-McElroy T
        • Mou SM
        • et al.
        Factor VII deficiency diagnosed after minor genital trauma.
        Haemophilia. 2017; 23: e133-e135
        • Ramsahoye BH
        • Davies SV
        • Dasani H
        • Pearson JF
        Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature.
        Haemophilia. 1995; 1: 140-144
        • Knol HM
        • Voskuilen MA
        • Holterman F
        • et al.
        Reproductive choices and obstetrical experience in Dutch carriers of haemophilia A and B.
        Haemophilia. 2011; 17: 233-236
        • Catanzarite VA
        • Novotny WF
        • Cousins LM
        • Schneider JM
        Pregnancies in a patient with congenital absence of prothrombin activity: case report.
        Am J Perinatol. 1997; 14: 135-138
        • Kulkarni AA
        • Lee CA
        • Kadir RA
        Pregnancy in women with congenital factor VII deficiency.
        Haemophilia. 2006; 12: 413-416
        • Hahn L
        • Lundberg PA
        Congenital hypofibrinogenaemia and recurrent abortion. Case report.
        Br J Obstet Gynaecol. 1978; 85: 790-793
        • Kelsey HA
        • Muirhead JM
        Severe postpartum haemorrhage associated with fibrinogen deficiency.
        Lancet. 1955; 269: 705-706
        • Miesbach W
        • Galanakis D
        • Scharrer I
        Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
        Blood Coagul Fibrinolysis. 2009; 20: 366-370
        • Myers B
        • Pavord S
        • Kean L
        • et al.
        Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency.
        Br J Obstet Gynaecol. 2007; 114: 643-646
        • Ellestad SC
        • Zimmerman SA
        • Thornburg C
        • et al.
        Severe factor V deficiency presenting with intracranial haemorrhage during gestation.
        Haemophilia. 2007; 13: 432-434
        • Whitelaw A
        • Haines ME
        • Bolsover W
        • Harris E
        Factor V deficiency and antenatal intraventricular haemorrhage.
        Arch Dis Child. 1984; 59: 997-999
        • Krikun G
        • Schatz F
        • Lockwood CJ
        Endometrial angiogenesis: from physiology to pathology.
        Ann N Y Acad Sci. 2004; 1034: 27-35